This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

TherapeuticsMD Inc (TXMD)

AMEX: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 54.19M 1.55M 126.42K 1.50K
Receivables 1.69M 606.64K 26.72K 5.59K
Inventories 1.04M 1.62M 588.07K 0.00
Other Current Assets 2.48M 751.94K 496.06K 0.00
Total Current Assets 59.40M 4.53M 1.24M 7.08K
Property, Plant & Equipment, Gross 155.08K 126.27K 151.61K 281.02K
Accumulated Depreciation & Depletion 93.76K 60.60K 81.50K 109.13K
Property, Plant & Equipment, Net 61.32K 65.67K 70.11K 171.89K
Intangibles 665.59K 239.56K 18.87K 0.00
Other Non-Current Assets 1.89M 985.60K 112.46K 0.00
Total Non-Current Assets 2.61M 1.29M 201.45K 460.33K
Liabilities & Shareholder Equity
Total Assets 62.02M 5.82M 1.44M 467.42K
Accounts Payable 2.11M 1.64M 506.51K 580.08K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 725.87K 41.36K 41.36K
Total Current Liabilities 7.32M 3.51M 3.15M 1.37M
Long Term Debt 0.00 3.59M 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 150.07K 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 3.74M 0.00 0.00
Total Liabilities 7.32M 7.25M 3.15M 1.37M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 54.70M -1.43M -1.71M -907.55K
Common Par 144.98K 99.78K 82.98K 16.58K
Additional Paid In Capital 135.09M 50.58M 15.20M 1.66M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -80.53M -52.11M -16.99M -2.59M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 54.70M 2.16M -1.71M -907.55K
Total Equity 54.70M -1.43M -1.71M -907.55K
Total Liabilities & Stock Equity 62.02M 5.82M 1.44M 467.42K
Total Common Shares Outstanding 144.98M 99.78M 82.98M 165.75K
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 127.57M 91.63M 62.52M 164.20K
Diluted Weighted Shares Outstanding 127.57M 91.63M 62.52M 164.20K
Number of Employees 69 69 51 1
Number of Part-Time Employees 0 0 0 0
TXMD News

TXMD TherapeuticsMD Inc

Analysts Ratings for TXMD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET TXMD ANALYST REPORT

Brokerage Partners

TXMD Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs